Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Spironolactone in Adult Congenital Heart Disease

Phase 2

Completed

Conditions: Endomyocardial Fibrosis
Congenital Heart Disease
Heart Failure

Interventions: Drug: Spironolactone 25mg
Other: Placebo

First Posted Date: 2010-02-17

Last Posted Date: 2019-08-21

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 40

Registration Number: NCT01069510

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease

Phase 1

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: Lipoic acid and fish oil concentrate
Drug: Placebo

First Posted Date: 2010-01-29

Last Posted Date: 2017-04-13

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 67

Registration Number: NCT01058941

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures

Phase 4

Completed

Conditions: Blood Loss
Anesthesia

Interventions: Other: No Sevoflurane
Drug: Sevoflurane

First Posted Date: 2010-01-13

Last Posted Date: 2017-08-09

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 160

Registration Number: NCT01048658

Locations: 🇺🇸
Lovejoy Surgicenter, Portland, Oregon, United States
🇺🇸
Oregon Health and Sciences University, Portland, Oregon, United States

Frozen Red Blood Cell Transfusions in Trauma Patients

Not Applicable

Completed

Conditions: Blood Loss
Anemia
Trauma

Interventions: Biological: RBC units

First Posted Date: 2009-12-24

Last Posted Date: 2020-01-28

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 254

Registration Number: NCT01038557

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States

and more 2 locations

The Energy Balance Study

Phase 1

Completed

Conditions: Obesity

Interventions: Other: Low carbohydrate diet
Other: High carbohydrate diet-energy matched intervention
Other: High-carbohydrate ad libitum intervention

First Posted Date: 2009-12-10

Last Posted Date: 2009-12-10

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 39

Registration Number: NCT01029483

The Physical Effects of Pain Catastrophizing in Labor

Completed

Conditions: Pregnancy

First Posted Date: 2009-11-13

Last Posted Date: 2019-07-29

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 91

Registration Number: NCT01012466

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Natural History of Levodopa-Induced Dyskinesia (LID)

Withdrawn

Conditions: Parkinson's Disease

Interventions: Drug: Levodopa (delivered intravenously)

First Posted Date: 2009-10-28

Last Posted Date: 2016-04-06

Lead Sponsor: Oregon Health and Science University

Registration Number: NCT01003002

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Preterm Neonatal Feeding Protocol Comparing Feed Administration Time

Not Applicable

Completed

Conditions: Feeding Intolerance

Interventions: Other: Length of time for feed administration

First Posted Date: 2009-10-19

Last Posted Date: 2019-06-10

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 136

Registration Number: NCT00997854

Locations: 🇺🇸
Oregon Health & Sciences University, Portland, Oregon, United States

Thrombelastography Based Dosing of Enoxaparin

Not Applicable

Completed

Conditions: Thromboembolic Complications

Interventions: Drug: Enoxaparin 30 mg BID
Drug: Enoxaparin dose adjusted Lovenox based on TEG

First Posted Date: 2009-10-06

Last Posted Date: 2020-04-03

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 185

Registration Number: NCT00990236

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States

Initial Test of the Time to Talk CARDIO (Creating a Real Dialogue In the Office) Program

Not Applicable

Completed

Conditions: Cardiovascular Disease
Cardiovascular Risk Factors

Interventions: Device: Time to Talk CARDIO website

First Posted Date: 2009-09-24

Last Posted Date: 2015-10-16

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 105

Registration Number: NCT00983333

Locations: 🇺🇸
Richmond Family Health Center at Oregon Health & Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy